Prime Medicine, Inc. (PRME) Capital expenditures 2020–2025
Prime Medicine, Inc. (PRME) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$4.5MFY2025 · since FY2020: $639,000 → $4.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.5M | -37.9% |
| FY2024 | $7.3M | -16.4% |
| FY2023 | $8.7M | -45.8% |
| FY2022 | $16.1M | +287.8% |
| FY2021 | $4.2M | +549.5% |
| FY2020 | $639,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice